>>Back
Supreme Court exposes GlaxoSmithKline to Humana's Avandia-spending claims
  • Publisher:
  • Publication:2013/4/17

        The U.S. Supreme Court declined to consider an appeal from GlaxoSmithKline ($GSK) in a fight over Humana's spending on the company's disgraced diabetes drug Avandia. The ruling not only opens GSK to the Humana suit, which applies to its Medicare Advantage plans, but also to potential lawsuits from other insurers.